Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra. The state of the law on psychedelic substances is in flux. 360bbb-0a.

Law 81

Law Therapy Clinical Trials Research and Development 81

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. These therapists will likely benefit from further decriminalization measures and may be able to transition to state-regulated systems as these go live.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Canna Law Blog

MARCH 4, 2020

Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).

Therapy 110

Therapy Legalization Chronic Pain DEA 110

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. cities and the State of Oregon have decriminalized them, and last November, Oregon voters legalized the supervised administration of psilocybin. Background. Due to their therapeutic and commercial potential, the U.S.

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

JUNE 29, 2021

The collaboration rests in the mutually held value to make these authors’ knowledge more accessible to a broader world-market. MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD.

Therapy 69

Therapy Research and Development Clinical Trials Education 69

SpeedWeed

JULY 6, 2021

By analyzing social, legal, and political barriers to access in this context, we hope to advance the understanding of their potential impact as therapeutics.”. The project also intends to advance research into how psychedelics can heal trauma and how to ensure equitable access to these therapies.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

JANUARY 14, 2020

CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE. The MORE Act would decriminalize marijuana and THC at the federal level by removing it from Schedule I of the Controlled Substances Act, which currently classifies it as an addictive drug that has no accepted medical use, akin to heroin. Legislation.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. But these substances remain illegal under federal law.

Law 74

Law Research and Development Therapy Treatment 74

The Cannigma

AUGUST 26, 2021

Medical: Legal Recreational: Illegal (though at least one territory has adopted decriminalization). The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials 52

Clinical Trials Events Medicine Therapy 52

MMJ Recs

JULY 3, 2024

Federally, the 2018 Farm Bill decriminalized hemp-derived CBD with less than 0.3% This variability can pose challenges for medical marijuana patients seeking consistent access to safe and effective CBD products, as well as for businesses aiming to comply with a patchwork of state laws. THC, marking a significant shift toward legality.

CBD 52

CBD Research and Development Clinical Trials THC 52

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Canna Law Blog

NOVEMBER 10, 2020

We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in certain cases, reliance on Right to Try access. It’s quite restrictive. Or, it could be because FDA is sort of a drag about everything.

Therapy 98

Therapy Clinical Trials Decriminalization Treatment 98

Canna Law Blog

NOVEMBER 27, 2021

In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction. BREAKING: City of Seattle Decriminalizes Psychedelics.

Therapy 98

Therapy Clinical Trials DEA Microdosing 98

Veriheal

DECEMBER 21, 2022

Rescheduling cannabis and decriminalizing cannabis do not mean the same thing for federal legalization. Decriminalization refers to the relaxation of criminal penalties associated with personal cannabis use. While both options seem better than the current situation, they could actually make it more difficult to access.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

Canna Law Blog

OCTOBER 8, 2020

For one, research on the benefits of psilocybin therapy in treating depression is farther along than most people think; the results are quite promising ; and more clinical trials are underway, including at esteemed research institutions like Johns Hopkins. See also: FDA Approves Drug Trial for Psilocybin (Magic Mushrooms).

Research and Development 74

Research and Development Decriminalization Clinical Trials Therapy 74

The Cannigma

MAY 7, 2021

The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. You’ve had this conversation in the US for over 20 years in some states so it’s not as if suddenly overnight, people have woken up to the discussion of cannabis and cannabis legalization and cannabis access. Music by Desca.

Supply Chain 126

Supply Chain Patients Access Hemp 126

Cannabis Law Report

MAY 29, 2022

7] And cities around the country are beginning to decriminalize some psychedelics, with advocates for decriminalization citing the potential medical benefits. In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 132

Legalization Patients Education Dispensary 132

Cannabis Law Report

FEBRUARY 10, 2022

Psilocybin’s therapeutic benefits are so promising that Denver, Colorado became the first city to decriminalize psilocybin in May 2019, and in 2020, Oregon passed Measure 109, which paved the road for a program allowing for legal manufacture, delivery, and administration of psilocybin to clients at supervised, licensed facilities in the state.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

DECEMBER 30, 2019

Now, nearly 1 in 4 Americans reside in a jurisdiction where the adult use of cannabis is legal, and 33 states regulate medical marijuana access. In the existing state-legal regulated marijuana marketplaces, businesses struggle to access basic banking services due to the federal prohibition of marijuana. A Pathway Towards SAFE Banking.

Legislation 45

Legislation Patients Access Banking 45

Canna Law Blog

MARCH 4, 2020

Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine. Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ).

Legalization 56

Legalization Therapy Chronic Pain DEA 56

Cannabis Law Report

JULY 21, 2022

By decriminalizing cannabis at the federal level, the CAOA also ensures that state-legal cannabis businesses or those in adjacent industries will no longer be denied access to bank accounts or financial services simply because of their ties to cannabis.

Safety 52

Safety Legislation Clinical Trials Banking 52

Cannabis Law Report

AUGUST 30, 2019

Americans for Safe Access released its 2018-2019 State-of-the-State report examining state laws and regulations surrounding Patient Rights and Civil Protection from Discrimination, Access to Medicine, Ease of Navigation, Functionality of the Programs, and Consumer Safety and Provider Requirements. Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

Canna Law Blog

NOVEMBER 6, 2021

Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. But only if it is made affordable and accessible. Instead, qualifying evidence may come from adequate and well-controlled clinical trials. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. In 2018, he helped guide the Decriminalize Denver campaign in the process of drafting the initiative text. Rick Doblin, Ph.D,

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Several bills have been introduced in Congress in 2019 that call for legalizing or decriminalizing the substance.

Law 40

Law Seed-To-Sale Hemp Recreational 40